Tangible Shareholders Equity: The value shareholders equity less intangible assets.
MAIA Biotechnology, Inc. (MAIA) had Tangible Shareholders Equity of $20.68M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.94M |
|
-- |
|
-- |
|
$8.32M |
|
$-8.32M |
|
$0.37M |
|
$-7.94M |
|
$-7.94M |
|
$-7.94M |
|
$-7.94M |
|
$-7.94M |
|
$-7.94M |
|
$-8.32M |
|
$-8.32M |
|
60.79M |
|
60.79M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$28.24M |
|
-- |
|
$0.00M |
|
$28.24M |
|
$6.26M |
|
-- |
|
$1.31M |
|
$7.57M |
|
$20.68M |
|
|
Tangible Shareholders Equity |
$20.68M |
$20.68M |
|
60.82M |
|
| Cash Flow Statement Financials | |
$-12.06M |
|
-- |
|
$30.99M |
|
$8.66M |
|
$27.60M |
|
$18.94M |
|
$1.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.42% |
|
-38.42% |
|
-28.13% |
|
-38.42% |
|
$0.34 |
|
$-0.20 |
|
$-0.20 |
|